US Needed Simple Pragmatic COVID-19 Trial For Repurposing Candidates, Woodcock Says
Executive Summary
One such trial is being developed, but was needed early in the pandemic to answer many lingering questions about potential COVID-19 treatments.
You may also be interested in...
Would Biden’s ‘Advanced Research’ Projects Mesh Well At NIH?
HHS Secretary Becerra answers questions about the scope of the proposed ARPA-H agency; more to come during NIH budget hearing.
Abernethy’s Departure From US FDA Gives Next Commissioner Options For A New Number Two
Janet Woodcock has been in the lead in the commissioner race for months without an announcement, but now serious doubts are being cast on her candidacy, including the tone of remarks at a White House press briefing.
EMA Turns Down Ivermectin As COVID-19 Treatment
The EU medicines regulator found that results from clinical studies with ivermectin to treat COVID-19 were varied and inconclusive.